Argus Investors' Counsel, Inc. Moderna, Inc. Transaction History

Argus Investors' Counsel, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 17, 2023	BUY	$96.41 - $126.61 $24,970 - $32,791	259 Added 5.35%	5,103 $527,000
Q2 2023 Jul 20, 2023	BUY	$118.5 - $160.53 $5,925 - $8,026	50 Added 1.04%	4,844 $588,000
Q1 2023 Apr 20, 2023	BUY	$135.66 - $197.02 $650,354 - $944,513	4,794 New	4,794 $736,000

940

240M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $13.3B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Argus Investors' Counsel, Inc., based on Form 13F filings with the SEC.

Stay updated on Argus Investors' Counsel, Inc. with notifications on news.